Brief: Allarity Therapeutics - Co Delinquent In Filing Form 10-Q For The Quarterly Period Ended June 30, 2022 With The SEC
Aug 22 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS - WE ARE DELINQUENT IN FILING OUR
FORM
10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022 WITH THE SEC
* ALLARITY THERAPEUTICS - MAY BE LATE IN FILING OTHER PERIOD
REPORTS WITH THE SEC IN THE FUTURE
Source: [https://bit.ly/3QYOyCE]
Further company coverage: ALLR.O
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic